VYOME HOLDINGS, INC. Repayments of Long-Term Debt
VYOME HOLDINGS, INC. (HIND) reported Repayments of Long-Term Debt of $10.50 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-04-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2023-04-17
- VYOME HOLDINGS, INC. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00.
- VYOME HOLDINGS, INC. repayments of long-term debt for the quarter ending 2021-09-30 was $0.00.
- VYOME HOLDINGS, INC. repayments of long-term debt for the quarter ending 2020-12-31 was $0.00.
- VYOME HOLDINGS, INC. repayments of long-term debt for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. repayments of long-term debt for fiscal 2021 was $10.50M.
- VYOME HOLDINGS, INC. repayments of long-term debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- VYOME HOLDINGS, INC. repayments of long-term debt for fiscal 2019 was $20.00M.
- VYOME HOLDINGS, INC. repayments of long-term debt for fiscal 2018 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $0.00 derived: sum of 2 quarters · filed 2023-04-17 | $10.50M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $10.50M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $10.50M 10-Q · filed 2022-08-19 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 10-K · filed 2021-03-12 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-07-30 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $5.00M derived: sum of 2 quarters · filed 2021-03-12 | $20.00M 10-K · filed 2021-03-12 | |
| 2019-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $20.00M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $15.00M 10-Q · filed 2020-07-30 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 10-K · filed 2020-02-27 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-24 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-02-23 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 | |||
| 2014-12-31 | $3.00M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |